Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Hemorrhagic | 2 | 2021 | 220 | 1.350 |
Why?
|
| Brain Edema | 6 | 2022 | 617 | 1.130 |
Why?
|
| Intracranial Hypertension | 5 | 2022 | 186 | 0.650 |
Why?
|
| Intracranial Pressure | 5 | 2022 | 326 | 0.530 |
Why?
|
| Blood Transfusion | 1 | 2021 | 1296 | 0.500 |
Why?
|
| Brain Injuries | 1 | 2022 | 2025 | 0.380 |
Why?
|
| TRPM Cation Channels | 2 | 2021 | 140 | 0.340 |
Why?
|
| Resuscitation | 2 | 2021 | 657 | 0.280 |
Why?
|
| Blood Pressure | 1 | 2021 | 8551 | 0.270 |
Why?
|
| Cerebral Hemorrhage | 3 | 2021 | 2647 | 0.230 |
Why?
|
| Glyburide | 1 | 2022 | 113 | 0.210 |
Why?
|
| Glasgow Coma Scale | 2 | 2021 | 570 | 0.200 |
Why?
|
| Endophenotypes | 1 | 2022 | 250 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 21824 | 0.190 |
Why?
|
| Isotonic Solutions | 1 | 2020 | 119 | 0.180 |
Why?
|
| Maze Learning | 1 | 2021 | 478 | 0.180 |
Why?
|
| Drug Repositioning | 1 | 2021 | 229 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 15525 | 0.160 |
Why?
|
| Fluid Therapy | 1 | 2021 | 593 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 1434 | 0.140 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2017 | 132 | 0.140 |
Why?
|
| Hypothermia, Induced | 1 | 2021 | 752 | 0.130 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2309 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18027 | 0.120 |
Why?
|
| Platelet Transfusion | 1 | 2017 | 314 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 931 | 0.110 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 1018 | 0.110 |
Why?
|
| Genotype | 4 | 2021 | 12956 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 1901 | 0.110 |
Why?
|
| Status Epilepticus | 1 | 2018 | 444 | 0.110 |
Why?
|
| Mice | 4 | 2022 | 81178 | 0.100 |
Why?
|
| Ticlopidine | 1 | 2017 | 899 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1916 | 0.090 |
Why?
|
| Male | 14 | 2022 | 350027 | 0.080 |
Why?
|
| Apoptosis | 2 | 2020 | 9728 | 0.070 |
Why?
|
| Animals | 4 | 2022 | 168788 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15538 | 0.070 |
Why?
|
| Seizures | 1 | 2018 | 2859 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 3674 | 0.060 |
Why?
|
| Aspirin | 1 | 2017 | 3282 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 3068 | 0.060 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2021 | 14 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3527 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2022 | 53280 | 0.050 |
Why?
|
| Female | 12 | 2021 | 380197 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 427 | 0.040 |
Why?
|
| Respiratory System | 1 | 2021 | 557 | 0.040 |
Why?
|
| Middle Aged | 10 | 2021 | 213367 | 0.040 |
Why?
|
| Aged | 9 | 2020 | 163253 | 0.040 |
Why?
|
| Humans | 15 | 2022 | 744220 | 0.040 |
Why?
|
| Glasgow Outcome Scale | 1 | 2017 | 109 | 0.040 |
Why?
|
| Epithelium | 1 | 2021 | 1680 | 0.040 |
Why?
|
| Atrophy | 1 | 2021 | 1582 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 1372 | 0.030 |
Why?
|
| Sex Factors | 2 | 2021 | 10396 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 35423 | 0.030 |
Why?
|
| Young Adult | 5 | 2020 | 56436 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 63119 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1677 | 0.030 |
Why?
|
| Minority Groups | 1 | 2021 | 1223 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1486 | 0.030 |
Why?
|
| Adolescent | 5 | 2020 | 85759 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2019 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Adult | 7 | 2021 | 214035 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 2702 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2021 | 6461 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2018 | 3588 | 0.020 |
Why?
|
| Risk Factors | 4 | 2018 | 72280 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2732 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3690 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 2987 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9849 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2022 | 4289 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2925 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29050 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6938 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14556 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2017 | 2508 | 0.020 |
Why?
|
| Pain | 1 | 2021 | 4987 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 40559 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13280 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57768 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12781 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8090 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18367 | 0.010 |
Why?
|
| United States | 2 | 2018 | 69867 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17449 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39045 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20945 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21752 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23404 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40063 | 0.010 |
Why?
|
| Brain | 1 | 2021 | 26413 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20123 | 0.010 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_